Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Cocrystal Pharma Inc COCP

Healthcare
Cocrystal Pharma, Inc. is a clinical-stage biotechnology company. The Company is engaged in discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses (including SARS-CoV-2), noroviruses and hepatitis C viruses (HCV). It is developing small molecule antiviral therapeutics that inhibit the essential viral replication function... see more

Recent & Breaking News (NDAQ:COCP)

Cocrystal Pharma Provides COVID-19 Impact Update on Development Programs

GlobeNewswire May 11, 2020

Cocrystal Pharma Expands Exclusive License Agreement with Kansas State University Research Foundation to New Coronavirus Antiviral Compounds with Novel Mechanism of Action

GlobeNewswire April 22, 2020

Cocrystal Pharma Announces Appointment of Nobel Laureate and Scientific Advisor, Roger D. Kornberg, Ph.D., to Board of Directors

GlobeNewswire April 20, 2020

Cocrystal Pharma to Present at the April 2020 Virtual Investor Summit

GlobeNewswire April 15, 2020

Cocrystal Pharma Reports 2019 Financial Results and Outlines Expected Value-Driving Milestones for 2020

GlobeNewswire March 30, 2020

Biotechs Offer a Glimmer of Hope Amid the Deadly COVID-19 Outbreak

Livemoney March 20, 2020

Trump's Gains Nearly All Lost as the Market Reacts to COVID-19

Livemoney March 19, 2020

Global Markets Are In Turmoil Sending Investors Scrambling For A Safe Haven

Livemoney March 13, 2020

Cocrystal Pharma Announces Closing of $6.8 Million Registered Direct Offering Priced At-the-Market

GlobeNewswire March 11, 2020

Cocrystal Pharma Announces $6.8 Million Registered Direct Offering Priced At-the-Market

GlobeNewswire March 9, 2020

Cocrystal Pharma Announces Plans to Advance Coronavirus Program

GlobeNewswire March 6, 2020

Cocrystal Pharma Announces Closing of $11.0 Million Registered Direct Offering Priced At-the-Market

GlobeNewswire February 28, 2020

Cocrystal Pharma Announces $11.0 Million Registered Direct Offering Priced At-the-Market

GlobeNewswire February 27, 2020

Cocrystal Pharma, Inc. Announces License Agreement with Kansas State University Research Foundation for Norovirus and Coronavirus Antiviral Compounds

GlobeNewswire February 24, 2020

Cocrystal Pharma Inc.'s Structure-Based Technology has Demonstrated Broad Utility in Development of Antivirals

GlobeNewswire February 13, 2020

Cocrystal Pharma Inc. to Present at Noble Capital Markets' 16th Annual Investor Conference

GlobeNewswire February 11, 2020

COCRYSTAL PHARMA, INC. ANNOUNCES CLOSING OF $2.2 MILLION REGISTERED DIRECT OFFERING

GlobeNewswire February 3, 2020

COCRYSTAL PHARMA, INC. PRICES $2.2 MILLION REGISTERED DIRECT OFFERING

GlobeNewswire January 29, 2020

Cocrystal Pharma to Present at the 12th Annual LD Micro Main Event

GlobeNewswire December 4, 2019

Cocrystal Pharma Reports Third Quarter 2019 Financial Results and Provides Corporate Update

GlobeNewswire November 12, 2019